凯赛生物 (688065.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(凯赛生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 770,790,398.11759,771,421.24684,521,536.95548,684,850.15535,060,039.70524,983,771.56505,446,207.40
 营业收入(元) 770,790,398.11759,771,421.24684,521,536.95548,684,850.15535,060,039.70524,983,771.56505,446,207.40
二、营业总成本(元) 653,690,059.75593,340,277.53559,743,411.09510,172,124.60457,477,850.94323,452,911.90441,820,904.84
 营业成本(元) 508,521,347.30505,155,886.59488,180,514.59385,733,624.35395,635,798.29390,608,140.89333,447,140.04
 研发费用(元) 68,737,867.2055,269,722.9044,784,258.6762,714,725.1240,245,940.0836,466,823.4649,700,532.11
 营业税金及附加(元) 8,966,734.459,836,498.338,671,464.878,944,334.074,747,667.275,792,416.418,225,011.94
 销售费用(元) 13,856,076.1114,393,220.8112,290,639.3010,779,180.878,653,702.546,703,800.5612,065,189.60
 管理费用(元) 46,195,789.2742,268,215.4243,243,992.0552,886,834.7840,166,682.2225,717,929.2665,179,136.97
 财务费用(元) 7,412,245.42-33,583,266.52-37,427,458.39-10,886,574.59-31,971,939.46-141,836,198.68-26,796,105.82
  其中:利息费用(元) 6,904,038.015,348,066.109,928,727.429,141,086.136,565,773.2210,196,873.056,268,059.68
  其中:利息收入(元) 42,405,804.0229,483,107.6645,659,719.2447,753,760.3954,985,497.0164,379,934.5352,651,494.08
 资产减值损失(元) -15,547,406.97-18,400,193.07-5,903,214.42-13,000,832.79-1,822,607.91--
 信用减值损失(元) -1,658,589.26-1,895,037.27-2,688,962.753,504,530.51-1,347,908.321,975,803.142,135,463.73
三、其他经营收益
 加:投资收益(元) -1,199,942.44-2,151,550.39-1,664,828.06-1,847,987.29-2,163,927.51-2,480,931.81-1,325,494.57
  其中:对联营企业和合营企业的投资收益(元) -1,199,942.44-2,151,550.39-1,664,828.06-1,847,987.29-2,163,927.51-2,480,931.81-1,325,494.57
 资产处置收益(元) ---1,207.99----
 其他收益(元) 9,889,194.8413,065,027.658,943,913.6128,589,641.9427,047,548.3233,293,576.9014,653,726.88
四、营业利润(元) 108,583,594.53157,050,598.62123,463,826.2555,752,292.4299,295,293.34220,158,586.7279,088,998.60
 加:营业外收入(元) 168,804.18128,230.11347,513.621,245,036.52295,857.15146,925.98154,907.27
 减:营业外支出(元) 2,248,639.49105,751.7616,429.04389,200.042,105,369.524,676,881.0141,905.18
五、利润总额(元) 106,503,759.22157,073,076.97123,794,910.8356,608,128.9097,485,780.97215,628,631.6979,202,000.69
 减:所得税费用(元) 12,177,450.8919,823,275.8716,937,299.351,416,461.048,610,056.5123,013,502.287,348,929.28
六、净利润(元) 94,326,308.33137,249,801.10106,857,611.4855,191,667.8688,875,724.46192,615,129.4171,853,071.41
(一)按经营持续性分类
  持续经营净利润(元) 94,326,308.33137,249,801.10106,857,611.4855,191,667.8688,875,724.46192,615,129.4171,853,071.41
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 97,731,810.48142,186,907.55105,258,699.9452,639,170.6372,027,467.73184,416,324.4957,441,388.49
  少数股东损益(元) -3,405,502.15-4,937,106.451,598,911.542,552,497.2316,848,256.738,198,804.9214,411,682.92
 扣除非经常性损益后的净利润(元) 95,560,299.67136,713,592.64102,994,926.6650,687,851.9552,701,901.68157,378,081.6045,784,034.69
七、每股收益
 一、基本每股收益(元) 0.170.240.180.090.130.310.10
 二、稀释每股收益(元) 0.170.240.180.090.130.310.10
八、其他综合收益(元) 3,009,875.56-717,083.11-2,075,953.82799,772.898,434,813.39-9,892,240.44-1,626,039.04
 归属于母公司股东的其他综合收益(元) 3,009,875.56-717,083.11-2,075,953.82799,772.898,434,813.39-9,892,240.44-1,626,039.04
九、综合收益总额(元) 97,336,183.89136,532,717.99104,781,657.6655,991,440.7597,310,537.85182,722,888.9770,227,032.37
 归属于母公司所有者的综合收益总额(元) 100,741,686.04141,469,824.44103,182,746.1253,438,943.5280,462,281.12174,524,084.0555,815,349.45
 归属于少数股东的综合收益总额(元) -3,405,502.15-4,937,106.451,598,911.542,552,497.2316,848,256.738,198,804.9214,411,682.92
公告日期 2024-10-312024-08-162024-04-302024-04-302023-10-312023-08-082023-04-27
审计意见(境内) 标准无保留意见

前瞻产业研究院